Relugolix combination therapy reduces uterine fibroid-associated bleeding for Black women

Once-daily relugolix combination therapy reduced heavy menstrual bleeding associated with uterine fibroids for most Black women, according to results of the LIBERTY long-term extension study.
“Despite many studies that demonstrate that Black/African American individuals with fibroids have more fibroids, more severe fibroid symptoms and more impairment of their quality of life from fibroids, relugolix combination therapy is an equally effective treatment option for these individuals and is well tolerated,” Elizabeth A. Stewart, MD, professor of obstetrics and gynecology in the

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart